Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CA7 | P43166 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | TACR1 | P25103 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL828589 | 1.00 | CA1 (0.51) | CA1CA2CA7CA9TSHR | |
| SCHEMBL8904530 | 1.00 | CA1 (0.51) | CA1CA2CA7CA9TSHR | |
| SCHEMBL19068463 | 0.96 | CA1 (0.49) | CA1CA2CA7CA9TSHR | |
| SCHEMBL19043237 | 0.93 | TSHR (0.45) | CA1CA2CA7CA9TSHR | |
| SCHEMBL4535810 | 0.88 | TSHR (0.58) | CA1CA2CA7CA9TSHR | |
| SCHEMBL5831617 | 0.88 | CA1 (0.47) | CA1CA2CA7CA9TSHR | |
| SCHEMBL1105206 | 0.88 | CA1 (0.47) | CA1CA2CA7CA9TSHR | |
| SCHEMBL14305767 | 0.87 | TSHR (0.46) | CA1CA2CA7CA9TSHR | |
| SCHEMBL11932961 | 0.86 | CA1 (0.50) | CA1CA2CA7CA9TSHR | |
| SCHEMBL227684 | 0.86 | TSHR (0.48) | CA1CA2CA7CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119114040-B | Preparation method and application of bionic phospholipid membrane monolithic column for screening and separating antimicrobial peptides | 佛山大学 | 2025-02-14 | — | — | CN | claimed |
| CN-119114040-A | Preparation method and application of bionic phospholipid membrane monolithic column for screening and separating antimicrobial peptides | 佛山大学 | 2024-12-13 | — | — | CN | claimed |
| EP-0130126-B1 | (S)-9-(2,3-DIHYDROXY-1-PROPOXYMETHYL) GUANINE AND ITS ACYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTIHERPETIC AGENTS | MERCK & CO. INC. (US) | 1987-08-26 | — | — | EP | claimed |
| EP-0130126-A1 | (S)-9-(2,3-dihydroxy-1-propoxymethyl) guanine and its acyl derivatives, their preparation and their application as antiherpetic agents | MERCK & CO. INC. (US) | 1985-01-02 | — | — | EP | claimed |
| JP-7149786-A | — | — | None | — | — | JP | disclosed |
| CN-119114040-B | Preparation method and application of bionic phospholipid membrane monolithic column for screening and separating antimicrobial peptides | 佛山大学 | 2025-02-14 | — | — | CN | disclosed |
| CN-119114040-A | Preparation method and application of bionic phospholipid membrane monolithic column for screening and separating antimicrobial peptides | 佛山大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-111448204-B | Vaccine against klebsiella pneumoniae | 爱杜西亚药品有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-11891413-B2 | Vaccine against Klebsiella pneumoniae | IDORSIA PHARMACEUTICALS LTD (CH) | 2024-02-06 | — | — | US | disclosed |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| CN-113024559-B | Preparation method of isoganciclovir | 上药康丽（常州）药业有限公司 | 2022-03-29 | — | — | CN | disclosed |
| US-20210386845-A1 | VACCINE AGAINST KLEBSIELLA PNEUMONIAE | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-12-16 | — | — | US | disclosed |
| EP-0327791-A1 | Gametocides | Monsanto Company (US) | 1989-08-16 | — | — | EP | disclosed |
| US-4847376-A | COLORIMETRIC ANALYSIS | BOEHRINGER MANNHEIM GMBH (DE) | 1989-07-11 | — | — | US | disclosed |
| US-4801710-A | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO., INC. (US) | 1989-01-31 | — | — | US | disclosed |
| US-4735649-A | HYDROXYALKYL ESTERS OF N-PHOSPHONOMETHYLCLYCINE | MONSANTO COMPANY (US) | 1988-04-05 | — | — | US | disclosed |
| EP-0130126-B1 | (S)-9-(2,3-DIHYDROXY-1-PROPOXYMETHYL) GUANINE AND ITS ACYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTIHERPETIC AGENTS | MERCK & CO. INC. (US) | 1987-08-26 | — | — | EP | disclosed |
| EP-0187297-A2 | Alkoxy methyl ether and alkoxy methyl ester derivatives | SYNTEX (U.S.A.) INC. (US) | 1986-07-16 | — | — | EP | disclosed |
| EP-0184473-A1 | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO. INC. (US) | 1986-06-11 | — | — | EP | disclosed |
| EP-0130126-A1 | (S)-9-(2,3-dihydroxy-1-propoxymethyl) guanine and its acyl derivatives, their preparation and their application as antiherpetic agents | MERCK & CO. INC. (US) | 1985-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891413-B2 | Vaccine against Klebsiella pneumoniae | UBXN1, MLX, UBXN4 | CA1 2985/4885CA2 4423/4885CA7 2849/4885 |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | CYP2C19, CYP3A7, CYP3A5 | CA1 4140/4885CA2 1930/4885CA7 1096/4885 |
| US-20210386845-A1 | VACCINE AGAINST KLEBSIELLA PNEUMONIAE | UBXN1, MLX, UBXN4 | CA1 2985/4885CA2 4423/4885CA7 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.